Pharma distributor’s licence cancelled over Kota deaths
The Rajasthan drug control department has cancelled the licence of a Kota-based pharmaceutical distributor accused of supplying fake oxytocin injections to hospitals. The decision was made after an inspection found fake oxytocin injections and several regulatory violations at the distributor's premises. The World Health Organisation has sought a report from the Union government on the case, which is linked to several maternal deaths at hospitals in Kota.
- ▪The licence cancellation was due to the distributor supplying fake oxytocin injections to hospitals in Kota.
- ▪The World Health Organisation has sought a report from the Union government on the case.
- ▪An inspection found fake oxytocin injections and several regulatory violations at the distributor's premises.
Hindustan Times — Top publishes from India and files mainly under world. We currently carry 1,839 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Hindustan Times — Top |
| Canonical URL | https://www.hindustantimes.com/india-news/pharma-distributor-s-licence-cancelled-over-kota-deaths-101782414911933.html |
| Publication time | Fri, 26 Jun 2026 06:10:08 +0530 |
| Retrieval time | 2026-06-26T01:33:41.038Z |
| Last seen | 2026-06-26T01:33:41.038Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | isCxtawidmxW |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Pharma distributor’s licence cancelled over Kota deathsRajasthan revoked a pharma distributor's license for supplying fake oxytocin linked to maternal deaths; WHO seeks a report amid ongoing investigations.Published on: Jun 26, 2026 6:10 AM ISTBy Yogendra Mahawar, KotaPrefer HTon GoogleShare viaCopy link The Rajasthan drug control department has cancelled the licence of a Kota-based pharmaceutical distributor accused of supplying fake oxytocin injections to Kota hospitals, where several women died after Caesarean deliveries, even as the World Health Organisation (WHO) has sought a report from the Union government on the case.Pharma distributor’s licence cancelled over Kota deathsThe matter pertains tofive maternal deaths at JK Lon Hospital and the Super Speciality Wing of the Government…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Hindustan Times — Top.
Discussion
0 commentsMore from Hindustan Times — Top
